Report copyright - Chemotherapy Protocol RENAL CELL AVELUMAB-AXITINIB...raised transaminases and an increased incidence of immune-related hepatitis (6.3%) with this regimen. If the ALT or AST is greater
Please pass captcha verification before submit form